A CHOC Children’s research project, under the direction of Philip H. Schwartz, Ph.D., senior scientist at the CHOC Children’s Research Institute and managing director of the facility’s National Human Neural Stem Cell Resource, has been awarded a $5.5 million grant from the California Institute for Regenerative Medicine (CIRM). The grant will be used to develop a stem cell-based therapy for the treatment of mucopolysaccharidosis (MPS I), a fatal metabolic disease that causes neurodegeneration, as well as defects in other major organ systems.
Based on a number of medical and experimental observations, children with inherited degenerative diseases of the brain are expected to be among the first to benefit from novel approaches based on stem cell therapy (SCT).
Dr. Schwartz explains, “While uncommon, pediatric genetic neurodegenerative diseases account for a large burden of mortality and morbidity in young children. Hematopoietic (bone marrow) stem cell transplant (HSCT) can improve some non-neural symptoms of these diseases, but does not treat the deadly neurodegenerative process. Our approach – targeting the effects of the disease on organs besides the brain with HSCT and neurodegeneration with a second stem cell therapy specifically designed to treat the brain – is a strategy for whole-body treatment of MPS I. Our approach is also designed to avoid the need for immunosuppressive drugs to prevent rejection of the transplanted cells.”
This research is designed to lead to experimental therapy, based on stem cells, by addressing two critical issues: early intervention is required and possible in this patient population; and “teaching” the immune system not to reject the transplanted cells is required. This research also sets the stage for efficient translation of this technology into clinical practice, by adapting transplant techniques that are standard in clinical practice or in clinical trials, and using laboratory cell biology methods that are easily transferrable to clinical cell manufacturing.
Nationally recognized for his work in the stem cell field, Dr. Schwartz’ research focuses on the use of stem cells to understand the neurobiological causes of autism and other neurodevelopmental disorders.
Named one of the best children’s hospitals by U.S. News & World Report (2011-2012) and a 2011 Leapfrog Top Hospital, CHOC Children's is exclusively committed to the health and well-being of children through clinical expertise, advocacy, outreach and research that brings advanced treatment to pediatric patients.
|01:00 AM||Technip, in Consortium with Samsung and Huanqiu, Awarded Contract for LNG Project in Canada|
|01:00 AM||Gemalto Integrates Qualcomm Technology to Enable Rapid and Cost Effective Design and Deployment of M2M Solutions|
|01:00 AM||OpenJaw Forms Strategic Alliance with TravelSky to Bring t-Retailing to China|
|12:01 AM||Global Capacity Selects Overture 6000 to Deliver Ethernet to Thousands of T1 Customers|
|12:01 AM||IEEE Celebrates Ethernet’s 40th Anniversary and Life-Changing Technologies That IEEE 802.3™ Standards Help Enable|
|12:01 AM||CEO of Immune Pharmaceuticals to Present at BioEquity Europe 2013|
|Tue, May 21, 2013|
|10:45 PM||Macquarie Infrastructure Company Appoints New President and CEO of HAWAI?IGAS|
|10:35 PM||Travis Pastrana Announces Inaugural Nitro Circus Live North American Tour|
|10:23 PM||Centerplate Sues Local 2 Unite Here for Alleged Violation of Federal Labor Law, Attempt to Eliminate Nonprofits in San Francisco AT&T Park Labor Dispute|
|10:00 PM||Star Scientific 72 Hour Deadline Alert: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Lead Plaintiff Motion Deadline in Securities Class Action Lawsuit Against Star|
|09:16 PM||Cinemark USA, Inc. Announces Pricing of $530 Million of 4.875% Senior Notes due 2023|
|08:56 PM||Automated Mobile Testing Smartens Up -- Testing in the Cloud Now Even Easier with Version 6 of Keynote DeviceAnywhere|
|08:48 PM||Intelsat Announces Pricing of Senior Notes|
|08:31 PM||Finelite’s Aaron Smith Wins Top Lighting Award|
|08:30 PM||Rosen Law Firm Announces Pendency of Action Against Keyuan Petrochemicals, Inc.|
|08:21 PM||PracticeMax Announces Acquisition of ABC Medical Management|
|08:20 PM||VCA Animal Hospitals Offers Free Boarding for Pets Affected by Oklahoma Tornadoes|
|08:00 PM||Mural Earns World Class Service Ranking with Net Promoter Score of 78|
|07:50 PM||Carbahal and McNaughton Elected to Lead the Board of First Northern Community Bancorp|
|07:36 PM||Notice to LPL Customers: The Securities Arbitration Law Firm of Klayman & Toskes Continues to Investigate and Pursue Claims Against LPL Financial as FINRA Levies $9 Million Fine|
|07:35 PM||Carmanah Announces Results of Annual General Meeting|
|07:28 PM||Rigrodsky & Long, P.A. Announces Investigation Of Meade Instruments Corp. Buyout|
|07:21 PM||CORRECTING and REPLACING InVivo Therapeutics Announces Webcast for Annual Shareholders Meeting to Be Held on May 23rd|
|07:17 PM||WeedMaps CEO Comments on Anticipated Election Results for Marijuana Initiatives in Los Angeles|
|07:15 PM||Law Offices of Howard G. Smith Announces Investigation of Websense, Inc.|
|07:03 PM||Xcel Energy Inc. Board Increases Common Dividend 3.7 Percent, Declares Dividend on Common Stock and Announces Management Changes|
|07:01 PM||Alison Kay appointed to lead Global Power & Utilities at Ernst & Young|
|07:00 PM||AMOLED Displays to Have Major Influence on Innovation in the Cloud Computing Era|
|06:55 PM||Law Offices of Howard G. Smith Announces Investigation of Overhill Farms, Inc.|
|06:50 PM||ExxonMobil Contributes to Tornado Recovery and Relief Efforts|
|More Press Releases From Business Wire News Releases|